|
MechanismBacterial DNA gyrase inhibitors [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date22 Oct 1987 |
|
MechanismBacterial DNA gyrase inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date01 Jan 1987 |
|
|
|
Originator Org.- |
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CA |
First Approval Date31 Dec 1951 |
100 Clinical Results associated with Ipca Pharma (Australia) Pty Ltd.
0 Patents (Medical) associated with Ipca Pharma (Australia) Pty Ltd.
100 Deals associated with Ipca Pharma (Australia) Pty Ltd.
100 Translational Medicine associated with Ipca Pharma (Australia) Pty Ltd.